Q3680495 (Q3680495): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed an Item: importing one item from France)
(‎Created claim: summary (P836): Neurodegenerative pathologies lead to progressive deterioration of nerve cells causing symptoms of dementia. There is currently no treatment available to cure or limit the evolution of this dementia. The ROGOWSKI project pursues the objective of developing molecular compounds targeting an enzyme expressed in neurons and whose function is critical for the regulation of microtubules structuring cells. Research on this enzyme should ultimately lim...)
Property / summary
 
Neurodegenerative pathologies lead to progressive deterioration of nerve cells causing symptoms of dementia. There is currently no treatment available to cure or limit the evolution of this dementia. The ROGOWSKI project pursues the objective of developing molecular compounds targeting an enzyme expressed in neurons and whose function is critical for the regulation of microtubules structuring cells. Research on this enzyme should ultimately limit the morphological change of cells and their deterioration by identifying new therapies that may use inhibitors of this enzyme. (English)
Property / summary: Neurodegenerative pathologies lead to progressive deterioration of nerve cells causing symptoms of dementia. There is currently no treatment available to cure or limit the evolution of this dementia. The ROGOWSKI project pursues the objective of developing molecular compounds targeting an enzyme expressed in neurons and whose function is critical for the regulation of microtubules structuring cells. Research on this enzyme should ultimately limit the morphological change of cells and their deterioration by identifying new therapies that may use inhibitors of this enzyme. (English) / rank
 
Normal rank
Property / summary: Neurodegenerative pathologies lead to progressive deterioration of nerve cells causing symptoms of dementia. There is currently no treatment available to cure or limit the evolution of this dementia. The ROGOWSKI project pursues the objective of developing molecular compounds targeting an enzyme expressed in neurons and whose function is critical for the regulation of microtubules structuring cells. Research on this enzyme should ultimately limit the morphological change of cells and their deterioration by identifying new therapies that may use inhibitors of this enzyme. (English) / qualifier
 
point in time: 18 November 2021
Timestamp+2021-11-18T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0

Revision as of 17:09, 18 November 2021

Project Q3680495 in France
Language Label Description Also known as
English
No label defined
Project Q3680495 in France

    Statements

    0 references
    84,306.4 Euro
    0 references
    297,688.0 Euro
    0 references
    28.32 percent
    0 references
    16 August 2017
    0 references
    15 August 2019
    0 references
    SATT AxLR SAS
    0 references
    Les pathologies neurodégénératives entraînent une détérioriation progressive des cellules nerveuses provoquant des symptômes de démence. Il n'existe aujourd'hui aucun traitement permettant de guérir cette démence ou d'en limiter l'évolution. Le projet ROGOWSKI poursuit l'objectif de développement de composés moléculaires ciblant une enzyme exprimée dans les neurones et dont la fonction est critique pour la régulation des microtubules structurant les cellules. Les recherches menées sur cette enzyme doivent permettre à terme de limiter le changement morphologique des cellules et leur détérioration, en identifiant de nouvelles thérapies susceptibles de faire usage d'inhibiteurs de cette enzyme. (French)
    0 references
    Neurodegenerative pathologies lead to progressive deterioration of nerve cells causing symptoms of dementia. There is currently no treatment available to cure or limit the evolution of this dementia. The ROGOWSKI project pursues the objective of developing molecular compounds targeting an enzyme expressed in neurons and whose function is critical for the regulation of microtubules structuring cells. Research on this enzyme should ultimately limit the morphological change of cells and their deterioration by identifying new therapies that may use inhibitors of this enzyme. (English)
    18 November 2021
    0 references

    Identifiers

    LR0015473
    0 references